1. Home
  2. GBIO vs OGI Comparison

GBIO vs OGI Comparison

Compare GBIO & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.55

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$1.78

Market Cap

218.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBIO
OGI
Founded
2016
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
218.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GBIO
OGI
Price
$5.55
$1.78
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$8.88
N/A
AVG Volume (30 Days)
60.0K
1.7M
Earning Date
11-05-2025
12-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,270,000.00
$186,075,713.00
Revenue This Year
N/A
$20.38
Revenue Next Year
N/A
$6.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$0.85
52 Week High
$12.40
$2.24

Technical Indicators

Market Signals
Indicator
GBIO
OGI
Relative Strength Index (RSI) 54.55 49.18
Support Level $5.40 $1.60
Resistance Level $5.69 $1.86
Average True Range (ATR) 0.21 0.17
MACD 0.03 -0.01
Stochastic Oscillator 65.99 34.67

Price Performance

Historical Comparison
GBIO
OGI

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: